Wednesday, June 22, 2022 1:29 AM
The first drop for presbyopia, Vuity (pilocarpine hydrochloride, Allergan), has recently gained FDA approval and has received much attention. It provides a pharmaceutical option beyond spectacles, contact lenses and surgery. The new drug is now readily available and easy to administer with fast onset and sufficient duration for most (about six hours). Even though this product has only been used for just a few months, reports have been positive.